Allogeneic stem cell transplant in patients with acute myeloid leukemia and karnofsky performance status score less than or equal to 80%: A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation (EBMT)-Reference-Cited by-同舟云学术

Allogeneic stem cell transplant in patients with acute myeloid leukemia and karnofsky performance status score less than or equal to 80%: A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation (EBMT)

Published:2020-11-26 Issue:1 Volume:10 Page:23-33
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med.

Author:

Saraceni Francesco¹^ORCID,Labopin Myriam²,Forcade Edouard³,Kröger Nicolaus⁴,Socié Gerard⁵,Niittyvuopio Riitta⁶,Cornelissen Jan J.⁷,Labussière‐Wallet Hélène⁸,Blaise Didier⁹,Choi Goda¹⁰,Byrne Jenny L.¹¹,Guillerm Gaelle¹²,Marchand Tony¹³,Esteve Jordi¹⁴,Bazarbachi Ali¹⁵,Savani Bipin¹⁶^ORCID,Olivieri Attilio¹,Nagler Arnon¹⁷,Mohty Mohamad²

Affiliation:

1. Hematology and Stem Cell Transplant Università Politecnica delle Marche Ancona Italy

2. EBMT Paris Study Office Saint Antoine Hospital Paris France

3. CHU Bordeaux Hôpital Haut‐leveque Pessac France

4. Bone Marrow Transplantation Centre University Hospital Eppendorf Hamburg Germany

5. Department of Hematology ‐ BMT Hopital St. Louis Paris France

6. HUCH Comprehensive Cancer Center Stem Cell Transplantation Unit Helsinki Finland

7. Department of Hematology Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam The Netherlands

8. Centre Hospitalier Lyon Sud Lyon France

9. Programme de Transplantation & Therapie Cellulaire Centre de Recherche en Cancérologie de Marseille Institut Paoli Calmettes Marseille France

10. University Medical Center Groningen (UMCG) Department of Hematology University of Groningen Groningen The Netherlands

11. Nottingham University Nottingham United Kingdom

12. C.H.R.U de Brest Service Onco‐Hematologie Brest France

13. Service d`Hematologie Clinique Adulte Centre Hospitalier Universitaire de Rennes Rennes France

14. Hospital Clínic Barcelona Spain

15. Bone Marrow Transplantation Program Department of Internal Medicine American University of Beirut Beirut Lebanon

16. Vanderbilt University Medical Center Nashville TN USA

17. Department of Bone Marrow Transplantation Chaim Sheba Medical Center Tel‐Hashomer Israel

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3593

Reference36 articles.

1. Validation of a combined comorbidity index

2. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

3. Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation

4. Performance Status and Comorbidity Predict Transplant-Related Mortality After Allogeneic Hematopoietic Cell Transplantation

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of MICB mismatches in unrelated haematopoietic stem cell transplantation;HLA;2024-06

2. Myeloablative Dose of Busulfan and Fludarabine Combined with In Vivo T Cell Depletion Is Safe and Effective Conditioning for Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients;Transplantation and Cellular Therapy;2023-11

4. Identifying the optimal conditioning intensity for stem cell transplantation in patients with myelodysplastic syndrome: a machine learning analysis;Bone Marrow Transplantation;2022-11-14

5. Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT);Bone Marrow Transplantation;2022-07-14